Thema: INE010B01027
Zydus Lifesciences, INE010B01027
money-6990721_1920.jpg - Foto: THN
Zydus Lifesciences stock faces profit pressure after Q2
Zydus Lifesciences stock reported strong September-quarter revenue growth despite a sharp decline in net profit. Higher expenses weighed on earnings.
ad-hoc-news.de, heute 02:19 Uhr
Zydus Lifesciences, INE010B01027
Zydus Lifesciences secured FDA review: Neutral rating for ...
The FYB206 filing targets a third-quarter 2027 decision. Zydus Lifesciences stock has INR 80.17 billion Q1 FY27 revenue and INR 9.40 billion profit.
ad-hoc-news.de, 19.10.26 01:50 Uhr
Zydus Lifesciences, INE010B01027
Zydus Lifesciences stock gets US generic launch
Zydus Lifesciences stock was at INR 1,163.80 on October 7, 2026, 5.54 percent below its 52-week high. Q1 FY27 revenue reached INR 80.17 billion.
ad-hoc-news.de, 07.10.26 07:16 Uhr
Zydus Lifesciences, INE010B01027
Zydus Lifesciences stock fell 1.40 percent as JV date moved ...
Zydus Lifesciences stock faced a December 2026 JV deadline after its Q1 FY27 profit fell 35.9 percent to INR 9.398 billion. Revenue rose 22 percent.
ad-hoc-news.de, 04.10.26 20:45 Uhr
Zydus Lifesciences, INE010B01027
Zydus Lifesciences Ltd stock (INE010B01027): shares stable ...
